儿科急性髓性白血病 - 新的方法
Seth E Karol1, Gwenaelle Gueguen2
1Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
Current opinion in hematology
|November 20, 2023
概括
新疗法正在改善急性髓性白血病 (AML) 的儿童的治疗结果. 针对性药物和免疫疗法的进展为减少儿科AML治疗失败和晚期毒性提供了希望.
科学领域:
- 儿科血液瘤学
- 癌症治疗方法 癌症治疗方法
- 白血病研究研究 白血病研究
背景情况:
- 患有急性髓性白血病 (AML) 的儿童面临高治疗失败率和晚期毒性,尽管缓解和生存率比成年人更好.
- 目前的治疗策略需要改进,以提高儿童AML患者的长期结果.
结论:
- 最近的发现正在显著改变儿科AML的治疗格局.
- 这些进展对于改善患者的治疗结果具有直接和长期的影响.
更多相关视频
10:49Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
Published on: September 18, 2013
18.2K
09:57Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
Published on: March 5, 2018
29.4K
相关概念视频
Bone Marrow Sampling and Transplants
334
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
334
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Differentiation of Common Myeloid Progenitor Cells
3.2K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.2K
